NLRP7
NACHT, LRR and PYD domains-containing protein 7
Also known as: CLR19.4, NALP7, NALP7_HUMAN, NOD12, PAN7, PYPAF3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WX94
- Gene
- NLRP7
- Ensembl
- ENSG00000167634
- Chromosome
- 19
- Canonical length
- 980 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
980 residues, UniProt reviewed canonical sequence.
>Q8WX94|NLRP7
1 MTSPQLEWTL QTLLEQLNED ELKSFKSLLW AFPLEDVLQK TPWSEVEEAD GKKLAEILVN
61 TSSENWIRNA TVNILEEMNL TELCKMAKAE MMEDGQVQEI DNPELGDAEE DSELAKPGEK
121 EGWRNSMEKQ SLVWKNTFWQ GDIDNFHDDV TLRNQRFIPF LNPRTPRKLT PYTVVLHGPA
181 GVGKTTLAKK CMLDWTDCNL SPTLRYAFYL SCKELSRMGP CSFAELISKD WPELQDDIPS
241 ILAQAQRILF VVDGLDELKV PPGALIQDIC GDWEKKKPVP VLLGSLLKRK MLPRAALLVT
301 TRPRALRDLQ LLAQQPIYVR VEGFLEEDRR AYFLRHFGDE DQAMRAFELM RSNAALFQLG
361 SAPAVCWIVC TTLKLQMEKG EDPVPTCLTR TGLFLRFLCS RFPQGAQLRG ALRTLSLLAA
421 QGLWAQMSVF HREDLERLGV QESDLRLFLD GDILRQDRVS KGCYSFIHLS FQQFLTALFY
481 ALEKEEGEDR DGHAWDIGDV QKLLSGEERL KNPDLIQVGH FLFGLANEKR AKELEATFGC
541 RMSPDIKQEL LQCKAHLHAN KPLSVTDLKE VLGCLYESQE EELAKVVVAP FKEISIHLTN
601 TSEVMHCSFS LKHCQDLQKL SLQVAKGVFL ENYMDFELDI EFERCTYLTI PNWARQDLRS
661 LRLWTDFCSL FSSNSNLKFL EVKQSFLSDS SVRILCDHVT RSTCHLQKVE IKNVTPDTAY
721 RDFCLAFIGK KTLTHLTLAG HIEWERTMML MLCDLLRNHK CNLQYLRLGG HCATPEQWAE
781 FFYVLKANQS LKHLRLSANV LLDEGAMLLY KTMTRPKHFL QMLSLENCRL TEASCKDLAA
841 VLVVSKKLTH LCLAKNPIGD TGVKFLCEGL SYPDCKLQTL VLQQCSITKL GCRYLSEALQ
901 EACSLTNLDL SINQIARGLW ILCQALENPN CNLKHLRLKT YETNLEIKKL LEEVKEKNPK
961 LTIDCNASGA TAPPCCDFFCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NLRP7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 3.7 nTPM
Expression across tissuesHPA
Tissue
- testis: 3.7 nTPM
- spleen: 0.6 nTPM
- ovary: 0.4 nTPM
- duodenum: 0.2 nTPM
- cervix: 0.1 nTPM
- colon: 0.1 nTPM
Single-cell type
- late spermatids: 7.9 nCPM
- oocytes: 4.6 nCPM
- undifferentiated spermatogonia: 4.4 nCPM
- late primary spermatocytes: 4.2 nCPM
- pdcs: 3.5 nCPM
- early spermatids: 3.1 nCPM
Immune cell
- plasmacytoid DC: 3.9 nTPM
- NK-cell: 0.6 nTPM
- gdT-cell: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NLRP7.
Disease | AllUniProt
Conditions NLRP7 is implicated in, by any mechanism.
- Hydatidiform mole, recurrent, 1 (HYDM1) MIM:231090
Disease | GeneticClinVar
26 pathogenic / likely-pathogenic of 403 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hydatidiform mole, recurrent, 1
- Oocyte/zygote/embryo maturation arrest 25
- Hydatidiform mole
- Gastric cancer
- NLRP7-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.51
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to interleukin-1
- cellular response to lipopolysaccharide
- negative regulation of cytokine production involved in inflammatory response
- negative regulation of interleukin-1 beta production
- negative regulation of protein processing
- regulation of inflammatory response
Molecular functions
- aspartic-type endopeptidase inhibitor activity
- ATP binding
- caspase binding
- identical protein binding
- interleukin-1 binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Leucine-rich repeat
- DAPIN domain
- NACHT nucleoside triphosphatase
- Death-like domain superfamily
- P-loop containing nucleoside triphosphate hydrolase
- Leucine-rich repeat domain superfamily
- NOD1/2, winged helix domain
- NACHT, LRR and PYD domains-containing protein, helical domain HD2
- NLRP family, innate immunity and inflammation regulators
- PAAD/DAPIN/Pyrin domain
- NACHT domain
- Leucine Rich repeat
- NLRC4 helical domain HD2
- NOD2 winged helix domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NLRP7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NLRP7 as an antibody target. Whether an autoantibody or antibody against NLRP7 could matter depends on whether native NLRP7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NLRP7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NLRP7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...